Investigation of Natural Derivatives as Inhibitors of Galectin and C - Reactive Protein via Molecular Docking Methodology
International Journal of Basic Science in Medicine · 30.03.2026 · 11 (1) · 18-24
DOI: 10.34172/ijbsm.47716 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Basic Science in Medicine, online erschienen am 30.03.2026. Verfasst von Yasin SarveAhrabi und 5 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Introduction
Galectin and C-reactive protein (CRP) have been extensively studied in association with cardiovascular diseases, serving as biomarkers indicative of cardiovascular health and risk. The biological activities of phytochemicals are significantly beneficial to human health. This study aims to evaluate the inhibitory effects of selected herbal compounds on galectin and CRP via molecular docking tools.
Methods
The two-dimensional (2D) structures of eight compounds were retrieved from the PubChem database. Ligands were optimized using the MM2 force field in Chem3D v20.1.1.125 software. The three-dimensional (3D) structures of galectin and CRP were obtained from the Protein Data Bank. Autodock Vina was utilized to assess the binding affinity of these ligands to the active sites of the proteins. The resulting data were analyzed using Discovery Studio v16.1.0 software.
Results
The findings indicated that atropine exhibited significant inhibitory effects on galectin by forming hydrogen bonds with the amino acids lysine, threonine, and glutamic acid. Additionally, caffeic acid demonstrated strong inhibitory activity against CRP (chain A) through the formation of hydrogen bonds with the amino acids arginine, glutamine, asparagine, and tryptophan. Among all tested compounds, caffeic acid emerged as the most effective and potent inhibitor against both proteins.
Conclusion
This study highlights the potential of both atropine and caffeic acid as significant inhibitors of galectin and CRP. These findings suggest that these compounds could be promising candidates for the treatment of conditions associated with adverse cardiac remodeling, heart failure, systemic inflammation, and heightened cardiovascular risk, particularly in relation to atherosclerosis.
Zitieren
APA
SarveAhrabi, Y., Khoei, S. N., Vahidi, M., Sarrafi, P. M., Parvin, H., & Ahrabi, N. Z. (2026). Investigation of Natural Derivatives as Inhibitors of Galectin and C - Reactive Protein via Molecular Docking Methodology. International Journal of Basic Science in Medicine, 11(1), 18-24. https://doi.org/10.34172/ijbsm.47716
Vancouver
SarveAhrabi Y, Khoei SN, Vahidi M, Sarrafi PM, Parvin H, Ahrabi NZ. Investigation of Natural Derivatives as Inhibitors of Galectin and C - Reactive Protein via Molecular Docking Methodology. International Journal of Basic Science in Medicine. 2026;11(1):18-24. doi:10.34172/ijbsm.47716
BibTeX
@article{SarveAhrabi2026,
author = {SarveAhrabi, Yasin and Khoei, Sarina Nejati and Vahidi, Mahsa and Sarrafi, Parmida Mohsen and Parvin, Helya and Ahrabi, Nakisa Zarrabi},
title = {Investigation of Natural Derivatives as Inhibitors of Galectin and C - Reactive Protein via Molecular Docking Methodology},
journal = {International Journal of Basic Science in Medicine},
year = {2026},
volume = {11},
number = {1},
pages = {18--24},
doi = {10.34172/ijbsm.47716}
}
EUVIMED